Oktafiani, Eka (2017) NALISIS EFEKTIVITAS BIAYA PENGGUNAAN INJEKSI SEFTRIAKSON DAN SEFOTAKSIM PADA PASIEN DEMAM TIFOID DI INSTALASI RAWAT INAP RUMAH SAKIT UMUM DAERAH AMBARAWA TAHUN 2016. Skripsi thesis, Universitas Setia Budi Surakarta.
Text
INTISARI.pdf Download (14kB) |
|
Text
SKRIPSI post ujian 2.pdf Download (2MB) |
Abstract
Typhoid fever is an acute infectious disease caused by Salmonella typhi. The disease has been reported in both developed and developing countries. Problems cited by the use of antibiotics in the treatment of this disease is Multi Drug Resistance (MDR), so the selection of alternative antibiotics become main factors to be considered in addition to cost contraints. This study aims to determine the cost effectiveness of ceftriaxone and cefotaxime injection therapy used in the treatment of typhoid fever in hospital Ambarawa. This research was conducted using Cost Effectiveness Analysis (CEA). This study used secondary data from patients with typhoid fever period from January to December 2016. Datas were taken from demographic data, length of stay and total cost. The results showed that the average total cost of the injection of ceftriaxone Rp. 1.838.427 while cefotaxime injection Rp. 1.761.722. The cost-effectiveness of ceftriaxone and cefotaxime injection therapy percentages respectively 100% with the ACER ceftriaxone Rp.18.384 and cefotaxime Rp.17.617. Group therapy cefotaxime injection is more cost effective compared with ceftriaxone injection therapy group. Keyword: Typhid fever, ceftriaxone, cefotaxime, CEA, ACER
Item Type: | Thesis (Skripsi) |
---|---|
Uncontrolled Keywords: | Typhid fever, ceftriaxone, cefotaxime, CEA, ACER |
Subjects: | R Medicine > R Medicine (General) |
Divisions: | Fakultas Farmasi > Prodi S1 Farmasi |
Depositing User: | Rohma Tri Wardani |
Date Deposited: | 25 Feb 2019 03:07 |
Last Modified: | 25 Feb 2019 03:07 |
URI: | http://repo.setiabudi.ac.id/id/eprint/1012 |
Actions (login required)
View Item |